blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

Latvia joins the Federated Register
Click here for more information on the Federated Register.

2025-04-16

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2949667

EP2949667 - RECOMBINANT CELL SURFACE CAPTURE PROTEINS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.03.2021
Database last updated on 26.04.2025
FormerThe patent has been granted
Status updated on  10.04.2020
FormerGrant of patent is intended
Status updated on  03.12.2019
FormerExamination is in progress
Status updated on  14.04.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591 / US
[2015/49]
Inventor(s)01 / DESHPANDE, Dipali
62 Eldorado Court
White Plains
Tarrytown, NY 10603 / US
02 / CHEN, Gang
1600 Fox Tail Lane
Yorktown Heights
Tarrytown, NY 10598 / US
03 / BURAKOV, Darya
10 Ashton Road
Yonkers, NY 10705 / US
04 / FANDL, James
40 Amanda's Way
LaGrangeville, NY 12540 / US
05 / ALDRICH, Thomas
2360 Bunney Court
Yorktown Heights, NY 10598 / US
06 / KAMAT, Vishal
129 Liberty Road
Apt. P
Bergenfield, NJ 07621 / US
 [2015/49]
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[N/P]
Former [2020/20]J A Kemp LLP
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Former [2015/49]Power, David
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Application number, filing date15172149.514.11.2013
[2015/49]
Priority number, dateUS201261726040P14.11.2012         Original published format: US 201261726040 P
[2015/49]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2949667
Date:02.12.2015
Language:EN
[2015/49]
Type: A3 Search report 
No.:EP2949667
Date:24.02.2016
Language:EN
[2016/08]
Type: B1 Patent specification 
No.:EP2949667
Date:13.05.2020
Language:EN
[2020/20]
Search report(s)(Supplementary) European search report - dispatched on:EP27.01.2016
ClassificationIPC:C07K16/18, C07K16/42, C12N15/10, C07K16/22, C07K16/28
[2015/49]
CPC:
C07K16/4258 (EP,IL,US); C07K16/42 (EP,IL,KR,US); C07K16/22 (EP,IL,US);
C07K16/2863 (EP,IL,KR,US); G01N33/5005 (IL); G01N33/68 (IL,KR);
C07K2317/31 (EP,IL,KR,US); C07K2317/526 (EP,IL,KR,US); C07K2317/622 (KR);
C07K2317/64 (EP,IL,KR,US); C07K2317/92 (EP,IL,KR,US); C07K2319/00 (KR) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/40]
Former [2015/49]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:REKOMBINANTE ZELLOBERFLÄCHENERFASSUNGSPROTEINE[2015/49]
English:RECOMBINANT CELL SURFACE CAPTURE PROTEINS[2015/49]
French:PROTÉINES RECOMBINANTES DE CAPTURE DE SURFACE CELLULAIRE[2015/49]
Examination procedure24.08.2016Examination requested  [2016/40]
05.10.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
09.12.2016Amendment by applicant (claims and/or description)
12.04.2017Despatch of a communication from the examining division (Time limit: M06)
17.10.2017Reply to a communication from the examining division
17.11.2017Despatch of a communication from the examining division (Time limit: M06)
25.05.2018Reply to a communication from the examining division
14.10.2019Date of oral proceedings
25.11.2019Minutes of oral proceedings despatched
04.12.2019Communication of intention to grant the patent
02.04.2020Fee for grant paid
02.04.2020Fee for publishing/printing paid
02.04.2020Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP13798483.7  / EP2920208
Opposition(s)16.02.2021No opposition filed within time limit [2021/16]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
09.12.2016Request for further processing filed
09.12.2016Full payment received (date of receipt of payment)
Request granted
02.01.2017Decision despatched
Fees paidRenewal fee
26.11.2015Renewal fee patent year 03
23.11.2016Renewal fee patent year 04
22.11.2017Renewal fee patent year 05
22.11.2018Renewal fee patent year 06
20.11.2019Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU14.11.2013
AL13.05.2020
AT13.05.2020
CY13.05.2020
CZ13.05.2020
EE13.05.2020
HR13.05.2020
LT13.05.2020
LV13.05.2020
MC13.05.2020
MK13.05.2020
MT13.05.2020
RO13.05.2020
RS13.05.2020
SI13.05.2020
SK13.05.2020
SM13.05.2020
TR13.05.2020
BG13.08.2020
GR14.08.2020
IS13.09.2020
PT14.09.2020
LU14.11.2020
[2022/32]
Former [2022/27]HU14.11.2013
AL13.05.2020
AT13.05.2020
CY13.05.2020
CZ13.05.2020
EE13.05.2020
HR13.05.2020
LT13.05.2020
LV13.05.2020
MC13.05.2020
MT13.05.2020
RO13.05.2020
RS13.05.2020
SI13.05.2020
SK13.05.2020
SM13.05.2020
TR13.05.2020
BG13.08.2020
GR14.08.2020
IS13.09.2020
PT14.09.2020
LU14.11.2020
Former [2021/33]AL13.05.2020
AT13.05.2020
CZ13.05.2020
EE13.05.2020
HR13.05.2020
LT13.05.2020
LV13.05.2020
MC13.05.2020
RO13.05.2020
RS13.05.2020
SI13.05.2020
SK13.05.2020
SM13.05.2020
BG13.08.2020
GR14.08.2020
IS13.09.2020
PT14.09.2020
LU14.11.2020
Former [2021/31]AL13.05.2020
AT13.05.2020
CZ13.05.2020
EE13.05.2020
HR13.05.2020
LT13.05.2020
LV13.05.2020
MC13.05.2020
RO13.05.2020
RS13.05.2020
SI13.05.2020
SK13.05.2020
SM13.05.2020
BG13.08.2020
GR14.08.2020
IS13.09.2020
PT14.09.2020
Former [2021/24]AL13.05.2020
AT13.05.2020
CZ13.05.2020
EE13.05.2020
HR13.05.2020
LT13.05.2020
LV13.05.2020
RO13.05.2020
RS13.05.2020
SI13.05.2020
SK13.05.2020
SM13.05.2020
BG13.08.2020
GR14.08.2020
IS13.09.2020
PT14.09.2020
Former [2021/10]AL13.05.2020
AT13.05.2020
CZ13.05.2020
EE13.05.2020
HR13.05.2020
LT13.05.2020
LV13.05.2020
RO13.05.2020
RS13.05.2020
SK13.05.2020
SM13.05.2020
BG13.08.2020
GR14.08.2020
IS13.09.2020
PT14.09.2020
Former [2021/09]AL13.05.2020
AT13.05.2020
CZ13.05.2020
EE13.05.2020
HR13.05.2020
LT13.05.2020
LV13.05.2020
RO13.05.2020
RS13.05.2020
SM13.05.2020
BG13.08.2020
GR14.08.2020
IS13.09.2020
PT14.09.2020
Former [2021/04]AL13.05.2020
HR13.05.2020
LT13.05.2020
LV13.05.2020
RS13.05.2020
BG13.08.2020
GR14.08.2020
IS13.09.2020
PT14.09.2020
Former [2021/01]HR13.05.2020
LT13.05.2020
LV13.05.2020
RS13.05.2020
BG13.08.2020
GR14.08.2020
IS13.09.2020
PT14.09.2020
Former [2020/51]HR13.05.2020
LT13.05.2020
LV13.05.2020
RS13.05.2020
GR14.08.2020
IS13.09.2020
PT14.09.2020
Former [2020/50]HR13.05.2020
LT13.05.2020
LV13.05.2020
GR14.08.2020
IS13.09.2020
PT14.09.2020
Former [2020/48]LT13.05.2020
IS13.09.2020
PT14.09.2020
Former [2020/47]LT13.05.2020
IS13.09.2020
Former [2020/46]IS13.09.2020
Documents cited:Search[A]EP0107509  (REPLIGEN CORP [US]);
 [IAY]WO02057423  (REGENERON PHARMA [US], et al);
 [IY]US2009137416  (FANDL JAMES P [US], et al);
 [YD]US2010331527  (DAVIS SAMUEL [US], et al);
by applicantUS5635354
 US6080840
 US6623957
 US6927044
 US7105348
 US7329731
 US2010331527
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.